Michelle Caroline;Timothy Michelsen; David M. Lorenz; Kathrin A.Dorfmüller
Inflammasomes are a group of protein complexes built around several proteins, including NLRP3, NLRC4, AIM2 and NLRP6. Recognition of a diverse range of microbial, stress and damage signals by inflammasomes results in direct activation of caspase-1, which subsequently induces secretion of potent pro-inflammatory cytokines and a form of cell death called pyroptosis. In the process of cardiac transplantation, the heart flushed and stored in cold preservation solution and then subsequently re-implanted and reperfused with warm blood. Its also occurs in several important clinical contexts including percutaneous coronary interventions for acute myocardial ischemia, and cardiac surgery in the setting of cardiopulmonary bypass. We performed heterotopic cardiac transplants in both wild-type mice and mice deficient in AIM 2 signaling due to a point mutation. Our data revealed that mice deficient in AIM 2 has evidenced of protction against cold I/R by improved cardiac function, inflammasomes/NLRP3, Bcl-2, Akt phosphorylation, and reduced myocardial apoptosis, Bax expression.
Keywords: Global myocardial I/R; AIM 2;Inflammasomes; NLRP3
You will have online immediate access to article following the completion of this purchase and you may download and print a copy of each article for your personal use.
Eberhardt F, Mehlhorn U, Larose K, DeVivie ER, Dhein S. Structural myocardial changes after coronary artery surgery. Eur J Clin Invest 2000; 30:938–946. [PubMed]
Dinarello CA. IL-1: discoveries, controversies and future directions. European Journal of Immunology 2010; 40(3):599–606. [Abstarct/Full-Text] http://dx.doi.org/10.1002/eji.201040319 20201008
Windecker S, Bax JJ, Myat A, Stone GW, Marber MS. Future treatment strategies in st-segment elevation myocardial infarction. Lancet 2013;382:644-657. [Abstarct/Full-Text] http://dx.doi.org/10.1016/S0140-6736(13)61452-X
Sellke FW, Ruel M. Vascular growth factors and angiogenesis in cardiac surgery. Ann Thorac Surg 2003;75(2):S685–90. [PubMed]
Strowig, Henao-Mejia J, E. Elinav, et al. Inflammasomes in health and disease. Nature 2012; 481(7381):278–286. [Abstarct/Full-Text] http://dx.doi.org/10.1038/nature10759 22258606
Vander Heide RS, Steenbergen C. Cardioprotection and myocardial reperfusion: Pitfalls to clinical application. Circ Res 2013;113:464-477. [PubMed] dx.doi.org/10.1161/CIRCRESAHA.113.300765.
Gross O, Thomas CJ, Guarda G, et al. The inflammasome: an integrated view. Immunological Reviews 2011; 243(1):136–151. [Abstarct/Full-Text] http://dx.doi.org/10.1111/j.1600-065X.2011.01046.x 21884173
Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death and Differentiation 2007; 14(1):10–22. [Abstarct/Full-Text] http://dx.doi.org/10.1038/sj.cdd.4402038 16977329
Verma S, Fedak PW, Weisel RD, et al. Off-pump coronary artery bypass surgery: fundamentals for the clinical cardiologist. Circulation 2004; 109:1206–1211. [Abstarct/Full-Text]
Park HH, Lo YC, Lin SC, et al. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annual Review of Immunology 2007; 25(2007):561–586. [Abstarct/Full-Text] http://dx.doi.org/10.1146/annurev.immunol.25.022106.141656 17201679
Zhu P, Duan L, Chen J, et al. Gene silencing of NALP3 protects against liver ischemia–reperfusion injury in mice. Human Gene Therapy 2011; 22(7):853–864. [Abstarct/Full-Text] http://dx.doi.org/10.1089/hum.2010.145 21128730
Choubey D, Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett 2008;119:32–41. [PubMed] dx.doi.org/10.1016/j.imlet.2008.06.001
Hornung V, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immuno. 2008;9:847–856. [PubMed] dx.doi.org/10.1038/ni.1631
Austin EW, Yousif NG, Ao L, Joseph C. Cleveland L, David A. Fullerton DA, Meng X. Ghrelin reduces myocardial injury following global ischemia and reperfusion via suppression of myocardial inflammatory response. American Journal of BioMedicine 2013; 1(2):38–48. [Abstarct/Full-Text] dx.doi.org/10.18081/ajbm/2333-5106-013-12/38-48
Agostini L, Martinon F, Burns K, et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004;20:319–325. [PubMed] http://dx.doi.org/10.1016/S1074-7613(04)00046-9
Masters SL, Dunne A, Subramanian SL. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nature Immunol 2010;11:897–904. [PubMed] dx.doi.org/10.1038/ni.1935.
Taxman DJ, Huang MT, Ting JP. Inflammasome inhibition as a pathogenic stealth mechanism. Cell Host Microbe 2010; 8(1):7–11. [Abstarct/Full-Text] http://dx.doi.org/10.1016/j.chom.2010.06.005 20638636
Patten RD, Aronovitz MJ, Deras-Mejia L, et al. Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol 1998; 274:H1812–H1820. [PubMed]
Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schönbeck U. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J. Exp. Med 2000; 191:1535–1544. [Abstarct/Full-Text]
Arslan F, de Kleijn DP, Pasterkamp G. Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 2011;8:292–300. [Abstarct/Full-Text] dx.doi.org/10.1038/nrcardio.2011.38.
Timmers L, Pasterkamp G, de Hoog VC, et al. The innate immune response in reperfused myocardium. Cardiovasc Res 2012; 94:276–283. [Abstarct/Full-Text] dx.doi.org/10.1093/cvr/cvs018.
Fan J, Li Y, Levy RM, et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 2007;178:6573–6580. [Abstarct/Full-Text]
Kang PM, Haunstetter A, Aoki H, Usheva A, Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 2000; 87:118–125. [PubMed]
Tsung A, Hoffman RA, Izuishi K, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005;175:7661–8. [PubMed]